Berkeley Communications
HTA in the news
December 19 2025
Trump Strikes 9 New Pricing Agreements as Drugmakers Navigate Tariff, Regulatory Pressure
American Journal of Managed Care
Trump secures new pricing deals with 9 drugmakers, advancing his effort to align US drug costs with Europe and expand direct-to-consumer purchasing.
Read more
December 19 2025
Will 2026 be the year of ICHRA?
Becker’s Payer Issues
Individual coverage health reimbursement arrangements are at an inflection point — payers are catching on, but not to the point of industry mass-adoption, and some employers still have their doubts.
Read more
December 2 2025
Why Express Scripts, OptumRX are losing ground to upstart PBMs
Modern Healthcare
Small and mid-sized pharmacy benefit managers sense an opportunity to grow market share headed into the new year.
Read more
November 26 2025
What lessons health plan leaders will bring into 2026
Becker's Payer Issues
In 2025, health plans put emerging tech to use, but also had to discover and utilize workarounds for government regulations from the current administration. For many payers, navigating the past year has helped them plan ahead for 2026.
Read more
November 10 2025
Insurers, Employers Face Pressure to Match Trump Deals on Drugs
Bloomberg Law
The Trump administration’s deal to lower the cash price of blockbuster weight-loss drugs is heightening pressure on employers and insurers to negotiate better costs with the drugmakers, say lawyers, academics, and executives.
Read more
November 6 2025
Obesity Drugs May Drop to as Little as $150 a Month
The New York Times
President Trump announced a deal with Eli Lilly and Novo Nordisk to lower prices on hugely popular weight-loss drugs for Medicare, Medicaid and American patients who pay their own money.
Read more
November 5 2025
TrumpRx Pfizer Drug Pricing
Pharmacy Practice News
The Trump administration’s newly unveiled “TrumpRx” initiative—a partnership with Pfizer framed as the first step toward applying most-favored-nation (MFN) drug pricing in the United States—is being touted as a game changer in making prescription drugs more affordable.
Read more
November 5 2025
TrumpRx Pfizer Drug Pricing
Specialty Pharmacy Continuum
The Trump administration’s newly unveiled “TrumpRx” initiative—a partnership with Pfizer framed as the first step toward applying most-favored-nation (MFN) drug pricing in the United States—is being touted as a game changer in making prescription drugs more affordable.
Read more